Disclosure Of Interests In Other Entities [Text Block]

ABIONYX Pharma - Filing #2810725

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of interests in other entities [text block]
i.
Disclosure of interests in subsidiaries [text block]
Disclosure of composition of group [text block]
La liste des sociétés consolidées est détaillée ci-dessous :
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
6 886 EUR
7 572 EUR
Non-current assets
7 948 EUR
8 251 EUR
Current liabilities
3 925 EUR
5 094 EUR
Non-current liabilities
2 987 EUR
3 560 EUR
Revenue
4 640 EUR
5 252 EUR
Profit (loss)
0 EUR
3 518 EUR
0 EUR
0 EUR
3 518 EUR
0 EUR
0 EUR
0 EUR
0 EUR
4 206 EUR
0 EUR
0 EUR
4 206 EUR
0 EUR
Comprehensive income
3 575 EUR
3 985 EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
4 104 EUR
4 046 EUR
Tax expense (income)
0 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.